The National Agency for Food and Drug Administration and Control (NAFDAC) has raised a public health alert over the circulation ...

DelveInsight’s, “Systemic Mastocytosis Pipeline Insight, 2025,” report provides comprehensive insights about 8+ companies and ...

The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for children aged 5 years of older with active lupus nephritis (LN) who are receiving standard therapy.

Mr. Jon E. RiceActing DirectorOffice of National Drug Control PolicyExecutive Office of the President Washington, D.C. 20503 RE: 2026 National Drug Control Strategy Dear Mr. Rice: The R Street ...

Promising Systemic Sclerosis Pipeline Therapies such as Divozilimab, Avenciguat (BI 685509), Nintedanib, GSK2330811, Riociguat (Adempas, BAY63-2521), Bosentan, Imatinib mesylate, Belimumab, Rituximab, ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of nemolizumab in treating patients ...

Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...

Merck, a leading science and technology company, today announced that the Center for Drug Evaluation (CDE) of the China National ...

The first six minutes of the flight to Southern California’s Ontario International Airport were routine. The Boeing 737 Max 9 ...

The systemic lupus erythematosus (SLE) treatment pipeline is experiencing unprecedented expansion, driven by increasing disease awareness, rising pre ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune‑mediated and metabolic diseases, today ...